Ligand Pharmaceuticals Incorporated Revenue per Employee (LGND), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ligand Pharmaceuticals Incorporated  (NASDAQ: LGND)
 

Ligand Pharmaceuticals Incorporated's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 33.73% in the second quarter 2026, year on year to cumulative value of $291 million, Ligand Pharmaceuticals Incorporated's revenue per employee grew on a trailing twelve months basis to $ 6,181,745, this marks a new company high.
Within the Healthcare sector Employees of 5 other companies have achieved higher revenue per employee. While Ligand Pharmaceuticals Incorporated's total ranking has deteriorated compared to the previous quarter from 143 to 155. Ligand Pharmaceuticals Incorporated has 47 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LGND Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 33.73 % 14.09 % 40.01 % 122.85 % 14.68 %
Sales per Employee (TTM) $ 6,181,745 5,839,915 5,703,979 5,341,213 3,986,979
LGND's Total Ranking # 155 # 143 # 586 # 591 # 829
Seq. Revenue Change 23.14 % -13.31 % -48.32 % 142.43 % 5.06 %

LGND Company Profile >> Back to LGND Efficiency Comparisons >> Compare LGND Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 6
Overall Market # 155

Revenue per Employee Statistics
High Average Low
$ 6,181,745 $ 3,287,326 $ 795,809
(Jun 30 2026)   (Mar 31 2013)



Financial Statements
Ligand Pharmaceuticals Incorporated's Revenue MRQ $ 64 Millions Visit LGND's Income Statement
Ligand Pharmaceuticals Incorporated's Revenues TTM $ 291 Millions Visit LGND's aggregate revenue growth
What are LGND's Sales? Visit LGND's Sales by Segment




Other Ratios
Ligand Pharmaceuticals Incorporated's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LGND's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LGND's Competitors
Revenue per Employee for LGND's Suppliers
Revenue per Employee for LGND's Customers

You may also want to know
LGND's Sales Growth Rates LGND's Pe Price to earnings ratio LGND's Receivables Turnover Ratio LGND's Stock Quote
LGND's Net Income Growth Rates LGND's Ps Price to Sales ratio LGND's Sales per Employee LGND's Asset Turnover Ratio
LGND's Net Margin LGND's Pb Price to Book ratio LGND's Financial Strength Ratios LGND's Dividend Payout Ratio
Date modified: 2026-08-14T20:33:37+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Arbutus Biopharma Corp  9,564,210.53 $ 181.720  Million 19 
Ligand Pharmaceuticals Incorporated  6,181,744.68 $ 290.542  Million 47 
Anika Therapeutics Inc   5,779,523.81 $ 121.370  Million 21 
Xeris Biopharma Holdings Inc   5,160,215.38 $ 335.414  Million 65 
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million 1 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.